Cargando…

An evaluation of the efficacy of a topical gel with Triester Glycerol Oxide (TGO) in the treatment of minor recurrent aphthous stomatitis in a Turkish cohort: A randomized, double-blind, placebo-controlled clinical trial

BACKGROUND: Triester glycerol oxide gel (Protefix® Queisser Pharma, Germany) is a new topical agent that has the property of adherence to the oral mucosa by forming a lipid film which protects against mechanical trauma and may help to reduce oral tissue moisture loss and inflammation. The aim of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ofluoglu, Duygu, Ergun, Sertan, Warnakulasuriya, Saman, Namdar-Pekiner, Filiz, Tanyeri, Hakkı
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359701/
https://www.ncbi.nlm.nih.gov/pubmed/28160585
http://dx.doi.org/10.4317/medoral.21469
_version_ 1782516426144219136
author Ofluoglu, Duygu
Ergun, Sertan
Warnakulasuriya, Saman
Namdar-Pekiner, Filiz
Tanyeri, Hakkı
author_facet Ofluoglu, Duygu
Ergun, Sertan
Warnakulasuriya, Saman
Namdar-Pekiner, Filiz
Tanyeri, Hakkı
author_sort Ofluoglu, Duygu
collection PubMed
description BACKGROUND: Triester glycerol oxide gel (Protefix® Queisser Pharma, Germany) is a new topical agent that has the property of adherence to the oral mucosa by forming a lipid film which protects against mechanical trauma and may help to reduce oral tissue moisture loss and inflammation. The aim of this clinical trial was to determine the efficacy of a topical TGO gel and to also compare it with triamcinolone acetonide pomade in the treatment of minor recurrent aphthous stomatitis. MATERIAL AND METHODS: This study was a randomized, double-blind, placebo-controlled clinical trial and 180 patients with the complaint of minor aphthous ulcers were enrolled in this study. The sociodemographic data and clinical characteristics of the ulcer were collected by questionnaire. Ulcer size and pain level measurements were performed and the efficacy indices for ulcer pain and size were calculated at day 0,2,4,6 by the same investigator. RESULTS: Significant differences were not detected among the demographics and ulcer histories including age, gender, onset of ulcer, mean healing time, family RAS history and ulcer localization between three groups. The pain score in TGO group was found statistically lower at day 2,4, and 6. Efficacy index and improvement rate of TGO group, regarding pain score, was higher than the other two groups at day 2 and 4. The reduction in ulcer size was statistically higher in TGO group than the other two groups at day 4 and 6. CONCLUSIONS: Topical application of TGO gel could decrease pain intensity, accelerate ulcer healing without any side effects, utilizing an easy appliable and accessible procedure. Therefore TGO gel could be a well-tolerated, safe, topical therapeutic agent in the clinical practice of RAS treatment. Key words:Topical therapy, triester glycerol oxide, triamcinolone acetonide, minor recurrent aphthous stomatitis.
format Online
Article
Text
id pubmed-5359701
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medicina Oral S.L.
record_format MEDLINE/PubMed
spelling pubmed-53597012017-03-24 An evaluation of the efficacy of a topical gel with Triester Glycerol Oxide (TGO) in the treatment of minor recurrent aphthous stomatitis in a Turkish cohort: A randomized, double-blind, placebo-controlled clinical trial Ofluoglu, Duygu Ergun, Sertan Warnakulasuriya, Saman Namdar-Pekiner, Filiz Tanyeri, Hakkı Med Oral Patol Oral Cir Bucal Research BACKGROUND: Triester glycerol oxide gel (Protefix® Queisser Pharma, Germany) is a new topical agent that has the property of adherence to the oral mucosa by forming a lipid film which protects against mechanical trauma and may help to reduce oral tissue moisture loss and inflammation. The aim of this clinical trial was to determine the efficacy of a topical TGO gel and to also compare it with triamcinolone acetonide pomade in the treatment of minor recurrent aphthous stomatitis. MATERIAL AND METHODS: This study was a randomized, double-blind, placebo-controlled clinical trial and 180 patients with the complaint of minor aphthous ulcers were enrolled in this study. The sociodemographic data and clinical characteristics of the ulcer were collected by questionnaire. Ulcer size and pain level measurements were performed and the efficacy indices for ulcer pain and size were calculated at day 0,2,4,6 by the same investigator. RESULTS: Significant differences were not detected among the demographics and ulcer histories including age, gender, onset of ulcer, mean healing time, family RAS history and ulcer localization between three groups. The pain score in TGO group was found statistically lower at day 2,4, and 6. Efficacy index and improvement rate of TGO group, regarding pain score, was higher than the other two groups at day 2 and 4. The reduction in ulcer size was statistically higher in TGO group than the other two groups at day 4 and 6. CONCLUSIONS: Topical application of TGO gel could decrease pain intensity, accelerate ulcer healing without any side effects, utilizing an easy appliable and accessible procedure. Therefore TGO gel could be a well-tolerated, safe, topical therapeutic agent in the clinical practice of RAS treatment. Key words:Topical therapy, triester glycerol oxide, triamcinolone acetonide, minor recurrent aphthous stomatitis. Medicina Oral S.L. 2017-03 2017-02-04 /pmc/articles/PMC5359701/ /pubmed/28160585 http://dx.doi.org/10.4317/medoral.21469 Text en Copyright: © 2017 Medicina Oral S.L. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ofluoglu, Duygu
Ergun, Sertan
Warnakulasuriya, Saman
Namdar-Pekiner, Filiz
Tanyeri, Hakkı
An evaluation of the efficacy of a topical gel with Triester Glycerol Oxide (TGO) in the treatment of minor recurrent aphthous stomatitis in a Turkish cohort: A randomized, double-blind, placebo-controlled clinical trial
title An evaluation of the efficacy of a topical gel with Triester Glycerol Oxide (TGO) in the treatment of minor recurrent aphthous stomatitis in a Turkish cohort: A randomized, double-blind, placebo-controlled clinical trial
title_full An evaluation of the efficacy of a topical gel with Triester Glycerol Oxide (TGO) in the treatment of minor recurrent aphthous stomatitis in a Turkish cohort: A randomized, double-blind, placebo-controlled clinical trial
title_fullStr An evaluation of the efficacy of a topical gel with Triester Glycerol Oxide (TGO) in the treatment of minor recurrent aphthous stomatitis in a Turkish cohort: A randomized, double-blind, placebo-controlled clinical trial
title_full_unstemmed An evaluation of the efficacy of a topical gel with Triester Glycerol Oxide (TGO) in the treatment of minor recurrent aphthous stomatitis in a Turkish cohort: A randomized, double-blind, placebo-controlled clinical trial
title_short An evaluation of the efficacy of a topical gel with Triester Glycerol Oxide (TGO) in the treatment of minor recurrent aphthous stomatitis in a Turkish cohort: A randomized, double-blind, placebo-controlled clinical trial
title_sort evaluation of the efficacy of a topical gel with triester glycerol oxide (tgo) in the treatment of minor recurrent aphthous stomatitis in a turkish cohort: a randomized, double-blind, placebo-controlled clinical trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359701/
https://www.ncbi.nlm.nih.gov/pubmed/28160585
http://dx.doi.org/10.4317/medoral.21469
work_keys_str_mv AT ofluogluduygu anevaluationoftheefficacyofatopicalgelwithtriesterglyceroloxidetgointhetreatmentofminorrecurrentaphthousstomatitisinaturkishcohortarandomizeddoubleblindplacebocontrolledclinicaltrial
AT ergunsertan anevaluationoftheefficacyofatopicalgelwithtriesterglyceroloxidetgointhetreatmentofminorrecurrentaphthousstomatitisinaturkishcohortarandomizeddoubleblindplacebocontrolledclinicaltrial
AT warnakulasuriyasaman anevaluationoftheefficacyofatopicalgelwithtriesterglyceroloxidetgointhetreatmentofminorrecurrentaphthousstomatitisinaturkishcohortarandomizeddoubleblindplacebocontrolledclinicaltrial
AT namdarpekinerfiliz anevaluationoftheefficacyofatopicalgelwithtriesterglyceroloxidetgointhetreatmentofminorrecurrentaphthousstomatitisinaturkishcohortarandomizeddoubleblindplacebocontrolledclinicaltrial
AT tanyerihakkı anevaluationoftheefficacyofatopicalgelwithtriesterglyceroloxidetgointhetreatmentofminorrecurrentaphthousstomatitisinaturkishcohortarandomizeddoubleblindplacebocontrolledclinicaltrial
AT ofluogluduygu evaluationoftheefficacyofatopicalgelwithtriesterglyceroloxidetgointhetreatmentofminorrecurrentaphthousstomatitisinaturkishcohortarandomizeddoubleblindplacebocontrolledclinicaltrial
AT ergunsertan evaluationoftheefficacyofatopicalgelwithtriesterglyceroloxidetgointhetreatmentofminorrecurrentaphthousstomatitisinaturkishcohortarandomizeddoubleblindplacebocontrolledclinicaltrial
AT warnakulasuriyasaman evaluationoftheefficacyofatopicalgelwithtriesterglyceroloxidetgointhetreatmentofminorrecurrentaphthousstomatitisinaturkishcohortarandomizeddoubleblindplacebocontrolledclinicaltrial
AT namdarpekinerfiliz evaluationoftheefficacyofatopicalgelwithtriesterglyceroloxidetgointhetreatmentofminorrecurrentaphthousstomatitisinaturkishcohortarandomizeddoubleblindplacebocontrolledclinicaltrial
AT tanyerihakkı evaluationoftheefficacyofatopicalgelwithtriesterglyceroloxidetgointhetreatmentofminorrecurrentaphthousstomatitisinaturkishcohortarandomizeddoubleblindplacebocontrolledclinicaltrial